Literature DB >> 19995881

Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

Riccardo Cappato1, Hugh Calkins, Shih-Ann Chen, Wyn Davies, Yoshito Iesaka, Jonathan Kalman, You-Ho Kim, George Klein, Andrea Natale, Douglas Packer, Allan Skanes, Federico Ambrogi, Elia Biganzoli.   

Abstract

BACKGROUND: The purpose of this study was to provide an updated worldwide report on the methods, efficacy, and safety of catheter ablation of atrial fibrillation (AF). METHODS AND
RESULTS: A questionnaire with 46 questions was sent to 521 centers from 24 countries in 4 continents. Complete interviews were collected from 182 centers, of which 85 reported to have performed 20,825 catheter ablation procedures on 16,309 patients with AF between 2003 and 2006. The median number of procedures per center was 245 (range, 2 to 2715). All centers included paroxysmal AF, 85.9% also included persistent and 47.1% also included long-lasting AF. Carto-guided left atrial circumferential ablation (48.2% of patients) and Lasso-guided ostial electric disconnection (27.4%) were the most commonly used techniques. Efficacy data were analyzed with centers representing the unit of analysis. Of 16,309 patients with full disclosure of outcome data, 10 488 (median, 70.0%; interquartile range, 57.7% to 75.4%) became asymptomatic without antiarrhythmic drugs and another 2047 (10.0%; 0.5% to 17.1%) became asymptomatic in the presence of previously ineffective antiarrhythmic drugs over 18 (range, 3 to 24) months of follow-up. Success rates free of antiarrhythmic drugs and overall success rates were significantly larger in 9590 patients with paroxysmal AF (74.9% and 83.2%) than in 2800 patients with persistent AF (64.8% and 75.0%) and 1108 patients with long-lasting AF (63.1% and 72.3%) (P<0.0001). Major complications were reported in 741 patients (4.5%).
CONCLUSIONS: When analyzed in a large number of electrophysiology laboratories worldwide, catheter ablation of AF shows to be effective in approximately 80% of patients after 1.3 procedures per patient, with approximately 70% of them not requiring further antiarrhythmic drugs during intermediate follow-up.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19995881     DOI: 10.1161/CIRCEP.109.859116

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  473 in total

Review 1.  Chemical transmitter systems in the brain.

Authors:  C C Shute
Journal:  Mod Trends Neurol       Date:  1975

2.  [Studies on the energy for sperm motility (author's transl)].

Authors:  K Imamura
Journal:  Nihon Funin Gakkai Zasshi       Date:  1975-10

3.  Continuation of vitamin K antagonists as acceptable anticoagulation regimen in patients undergoing pulmonary vein isolation.

Authors:  B Oude Velthuis; J Stevenhagen; J M van Opstal; M F Scholten
Journal:  Neth Heart J       Date:  2012-01       Impact factor: 2.380

4.  Pulmonary venous isolation versus additional substrate modification as treatment for paroxysmal atrial fibrillation.

Authors:  Andrew Robertson Gavin; Cameron B Singleton; John Bowyer; Andrew D McGavigan
Journal:  J Interv Card Electrophysiol       Date:  2011-09-21       Impact factor: 1.900

5.  Ablation for atrial fibrillation: what are acceptable levels of experience, efficacy, and complications?

Authors:  Kelley P Anderson
Journal:  J Interv Card Electrophysiol       Date:  2012-03-09       Impact factor: 1.900

6.  Randomized comparison of contact force-guided versus conventional circumferential pulmonary vein isolation of atrial fibrillation: prevalence, characteristics, and predictors of electrical reconnections and clinical outcomes.

Authors:  Kohki Nakamura; Shigeto Naito; Takehito Sasaki; Masahiro Nakano; Kentaro Minami; Yosuke Nakatani; Kentaro Ikeda; Eiji Yamashita; Koji Kumagai; Nobusada Funabashi; Shigeru Oshima
Journal:  J Interv Card Electrophysiol       Date:  2015-09-19       Impact factor: 1.900

7.  Phrenic nerve palsy during ablation of atrial fibrillation using a 28-mm cryoballoon catheter: predictors and prevention.

Authors:  Michael Kühne; Sven Knecht; David Altmann; Nadine Kawel; Peter Ammann; Beat Schaer; Stefan Osswald; Christian Sticherling
Journal:  J Interv Card Electrophysiol       Date:  2012-10-23       Impact factor: 1.900

8.  Long-term outcomes (>2 years) of atrial fibrillation ablation using a multi-electrode ablation catheter in patients with paroxysmal atrial fibrillation.

Authors:  Khang-Li Looi; Parag Gajendragadkar; Tamer Taha; Maros Elsik; Elizabeth Scully; Patrick Heck; Simon Fynn; Munmohan Virdee; David Begley
Journal:  J Interv Card Electrophysiol       Date:  2012-10-25       Impact factor: 1.900

9.  Predictors of non-pulmonary vein foci in paroxysmal atrial fibrillation.

Authors:  Keita Watanabe; Junichi Nitta; Osamu Inaba; Akira Sato; Yukihiro Inamura; Nobutaka Kato; Masahito Suzuki; Masahiko Goya; Kenzo Hirao; Tetsuo Sasano
Journal:  J Interv Card Electrophysiol       Date:  2020-05-28       Impact factor: 1.900

10.  Non-fluoroscopic catheter visualization using MediGuide™ technology: experience from the first 600 procedures.

Authors:  P Sommer; S Richter; G Hindricks; S Rolf
Journal:  J Interv Card Electrophysiol       Date:  2014-01-16       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.